Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COBW domain containing protein pseudogene (Ensembl: ENSG00000204790), also known as LOC728877 or COBW domain containing 3 pseudogene, is classified as a **pseudogene** in the human genome[1][4][7]. Pseudogenes are gene sequences that share high sequence similarity to functional genes but are themselves non-functional due to disabled coding regions or inherited mutations preventing protein production[3]. There is no evidence that this pseudogene encodes a functional protein, nor is it associated with any known therapeutic mechanism, drug interaction, or disease role[4][7]. The naming refers to its homology with COBW domain-containing proteins, which in other species or paralogs may have functions involving metal ion (such as nickel or cobalamin/vitamin B12) chaperoning, but this specific locus does not encode an active protein and is not considered a druggable or biological target in medicine or pharmacology[3][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COBW domain containing protein pseudogene.